![Expert Q&A: Key Developments in AI and Digital Pathology](https://www.g2intelligence.com/wp-content/uploads/2023/10/Nov23.CDI-DTET-DigitalPathology-AI-Trends-Paige-iStock-1356018446-1800x1250-1-1080x675.jpg)
Expert Q&A: Key Developments in AI and Digital Pathology
Juan Antonio Retamero, MD, shares his thoughts on recent trends in AI and digital pathology, and how they may progress.
Juan Antonio Retamero, MD, shares his thoughts on recent trends in AI and digital pathology, and how they may progress.
Liron Pantanowitz, MD, PhD, discusses the key issues pathologists face today, and how technology could help.
AI is an increasingly useful tool in pathology—but its full value can only be realized in collaboration with human experts.
Inadequate CMS oversight resulted in $888.2 million in improper payments for the highest reimbursing molecular pathology genetic tests, report says.
Labs will have to submit Z-Codes with every molecular pathology testing code billed to UnitedHealthcare, starting Aug. 1.